Mustang Bio Company
Mustang Bio is a clinical-stage biopharmaceutical company .
.png)
Funding Status:
IPO
Investors Number:
4
Last Funding Date:
2022-03-08
Headquarters:
New York, New York, United States
Last Funding Type:
Post-IPO Debt
Total Funding:
204300000
Founded Date:
2015-01-01
Industry:
CAR-T
Estimated Revenue:
$10M to $50M